Bal Pharma Announcements
Certificate under Regulation 74(5) of SEBI(DP) Regulations, for the quarter ended 31.03.2026.
06 Apr, 2026 | 12:41pm • Source: BSE
Closure of Trading Window for the quarter and financial year ended 31.03.2026.
23 Mar, 2026 | 12:46pm • Source: BSE
Newspaper publication of Unaudited financial results for the quarter ended 31.12.2025.
16 Feb, 2026 | 02:52pm • Source: BSE
Dr.Mukesh Beekamchand ( DIN # 11295580 ) is appointed as Non executive Independent Director of the Company through an ordinary resolution passed by the members...
09 Feb, 2026 | 06:34pm • Source: BSE
Bal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 ,inter alia, to consider and...
03 Feb, 2026 | 03:50pm • Source: BSE
We are submitting newspaper advertisements of the postal ballot notice issued by the Company on 08.01.2026 and published on 09.01.2026.
12 Jan, 2026 | 04:50pm • Source: BSE
Confirmation as per Regulation 74(5) of SEBI(DP) Regulations, for the quarter ended 31.12.2025.
09 Jan, 2026 | 12:18pm • Source: BSE
Postal Ballot notice for appointment of Dr.Mukesh Beekamchand ( DIN # 11295580) as independent Director of the Company.
08 Jan, 2026 | 03:59pm • Source: BSE
Trading Window Closure from 1st January 2026 to 16th February 2026- for announcing unaudited financial results for the quarter ended 31.12.2025.
23 Dec, 2025 | 12:49pm • Source: BSE
We are submitting to the exchanges, news paper advertisements of the unaudited standalone and consolidated financial results of the company for the quarter ended 30.09.2029...
17 Nov, 2025 | 04:17pm • Source: BSE
Unaudited standalone and Consolidated financial results for the quarter ended 30.09.2025.
12 Nov, 2025 | 06:56pm • Source: BSE
Board of Directors of the Company has inter alia 1. Approved the unaudited standalone and consolidate financial results for the quarter ended 30.09.2025. 2. Appointed...
12 Nov, 2025 | 06:49pm • Source: BSE
Clarification on the outcome of the board meeting held on 11.08.2025.
07 Nov, 2025 | 03:00pm • Source: BSE
Bal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and...
04 Nov, 2025 | 04:44pm • Source: BSE
Compliance Certificate for the quarter ended 30.09.2025, as per SEBI(PIT) Regulations,2015
24 Oct, 2025 | 12:28pm • Source: NSE
Confirmation as per Regulation 74(5) of SEBI(DP) Regulations for the quarter ended 30.09.2025.
06 Oct, 2025 | 12:11pm • Source: BSE
Completion of term of Mr.H.S Venkatesh ( DIN # 01776040) as Independent Director of the Company.
30 Sep, 2025 | 03:12pm • Source: BSE
Trading Window on dealing with the securities of the Company will be closed from 1st October 2025 until 48 hours of announcement of Unaudited financial...
26 Sep, 2025 | 04:18pm • Source: BSE
Outcome of the 38th Annual General Meeting of the Company.
25 Sep, 2025 | 03:41pm • Source: BSE
Newpaper Publication for Notice for the 38th Annual General Meeting of the Company together with e-voting and Book closure .
03 Sep, 2025 | 04:13pm • Source: BSE